NEO Competitors & Alternatives
Compare NeoGenomics Inc with similar stocks in the same industry
Diagnostics & Research
NEO
Main Stock$9.02
Tradestie Score
61
Market Cap
$1.13B
Revenue Growth
0.1%
Analyst Upside
+57.3%
Top Competitors
33 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$66.07
|
$3.26B | - | 59 | Compare |
|
VCYT
Veracyte, Inc.
|
$33.43
|
$2.85B | 41.3 | 57 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$52.20
|
$2.24B | - | 53 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$59.15
|
$1.77B | - | 63 | Compare |
|
NVCR
NovoCure Limited Ordinary Shares
|
$12.12
|
$1.56B | - | 60 | Compare |
|
NEOG
Neogen Corp
|
$9.34
|
$1.26B | - | 55 | Compare |
|
OPK
Opko Health Inc.
|
$1.21
|
$1.23B | - | 63 | Compare |
|
CDNA
CareDx, Inc.
|
$21.91
|
$798.40M | - | 62 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$24.69
|
$667.77M | - | 56 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$5.50
|
$612.76M | - | 53 | Compare |
More NEO Analysis
Data updated: Apr 29, 2026 | Industry: Diagnostics & Research (SIC 8734)
33 stocks in this industry